0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0264
Includes: Supplemental Content

JAMA Oncology | 
Brief Report |  ONLINE FIRST
M. Estela Martinez-Escala, MD; Timothy M. Kuzel, MD; Jason B. Kaplan, MD; et al.
JAMA Oncol. Published online April 07, 2016. doi:10.1001/jamaoncol.2016.0004
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Susan E. Bates, MD; Larisa J. Geskin, MD
JAMA Oncol. Published online April 07, 2016. doi:10.1001/jamaoncol.2016.0072

JAMA Oncology | 
Research Letter | 
Lecia V. Sequist, MD, MPH; Zofia Piotrowska, MD; Matthew J. Niederst, PhD; et al.
JAMA Oncol. 2016;2(4):541-543. doi:10.1001/jamaoncol.2015.5009.

JAMA Neurology | 
Editorial |  ONLINE FIRST
Mark S. Baron, MD
JAMA Neurol. Published online March 21, 2016. doi:10.1001/jamaneurol.2016.0213

JAMA Internal Medicine | 
Editorial |  ONLINE FIRST
Mitchell H. Katz, MD
JAMA Intern Med. Published online March 15, 2016. doi:10.1001/jamainternmed.2016.0664

JAMA Neurology | 
Editorial |  Open Access ONLINE FIRST
William Renthal, MD, PhD
JAMA Neurol. Published online March 15, 2016. doi:10.1001/jamaneurol.2016.0535

JAMA Psychiatry | 
Editorial | 
John M. Kane, MD; Christoph U. Correll, MD
JAMA Psychiatry. 2016;73(3):187-188. doi:10.1001/jamapsychiatry.2015.2966.

JAMA Psychiatry | 
Original Investigation | 
Myrto T. Samara, MD; Markus Dold, MD; Myrsini Gianatsi, MSc; et al.
JAMA Psychiatry. 2016;73(3):199-210. doi:10.1001/jamapsychiatry.2015.2955.
Includes: CME, Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5932
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib A Phase 2 Clinical Trial
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncology
Brief Report  | 
Durable Responses With Maintenance Dose-Sparing Regimens of Romidepsin in Cutaneous T-Cell Lymphoma
M. Estela Martinez-Escala, MD; Timothy M. Kuzel, MD; Jason B. Kaplan, MD; et al.
JAMA Oncology
Invited Commentary  | 
Romidepsin Therapy Over 5 Years in a Clinical Setting—Real-World Experience
Susan E. Bates, MD; Larisa J. Geskin, MD
JAMA Oncology
Research Letter  | 
Osimertinib Responses After Disease Progression in Patients Who Had Been Receiving Rociletinib
Lecia V. Sequist, MD, MPH; Zofia Piotrowska, MD; Matthew J. Niederst, PhD; et al.